NCT05056116 2021-12-27A Safety and Efficacy Study of Surufatinib Combination With Toripalimab in Patients With Recurrent Biliary Tract CancerThe Affiliated Hospital of Xuzhou Medical UniversityPhase NA Unknown30 enrolled